RWM
JAZZ icon

Rialto Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rialto Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.03K Buy
25
+7
+39% +$1.53K ﹤0.01% 679
2026
Q1 		$3.4K Buy
18
+2
+13% +$350 ﹤0.01% 688
2025
Q4 		$2.72K Buy
16
+1
+7% +$153 ﹤0.01% 637
2025
Q3 		$1.98K Buy
15
+1
+7% +$120 ﹤0.01% 675
2025
Q2 		$1.49K Buy
+14
New +$1.52K ﹤0.01% 687

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Rialto Wealth Management's JAZZ Position: Q2 2026 in Review

Rialto Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 39% in Q2 2026, buying an estimated $1.53K and bringing the position to 25 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Rialto Wealth Management first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Rialto Wealth Management held 25 shares of Jazz Pharmaceuticals worth $6.03K as of Q2 2026.
  • Rialto Wealth Management bought 7 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.53K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #679 holding.
  • Rialto Wealth Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.